FABP4 and colorectal carcinoma: Higher FABP‐4 levels were associated with an increased risk of CRC‐specific mortality (HR per SD = 1.46; 95% CI: 1.16–1.84) and all‐cause mortality (HR = 1.39; 95% CI: 1.12–1.71) in distal colon cancer but not proximal colon cancer (Figure 2).